Liver-directed therapies: Does it make sense in the current therapeutic strategy for patients with confined liver colorectal metastases?

Clinical Colorectal Cancer

Volumn 11, Issue 3, 2012, Pages 177-184

  Seront, E ^a   Van Den Eynde, M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Colorectal cancer; Hepatic arterial infusion; Liver metastases; Liver directed therapy; Review; Yttrium 90 microsphere

Indexed keywords

CETUXIMAB; CISPLATIN; DOXIFLURIDINE; DOXORUBICIN; FIRTECAN; FLOXURIDINE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN; OXALIPLATIN; PIRARUBICIN; YTTRIUM 90;

CANCER CONTROL; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMORADIOTHERAPY; COLORECTAL CANCER; LIVER CIRCULATION; LIVER COLORECTAL METASTASIS; LIVER DIRECTED THERAPY; LIVER METASTASIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT INDICATION; TREATMENT RESPONSE;

EID: 84865453067     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.12.004     Document Type: Review

References (67)

1. J.B. O'Connell, M.A. Maggard, C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 2004 1420 1425
2. A. Jemal, R. Siegel, E. Ward Cancers statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. G.D. Leonard, B. Brenner, N.E. Kemeny Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma J Clin Oncol 23 2005 2038 2048
4. R. Adam, D.A. Wicherts, R.J. de Haas Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27 2009 1829 1835
5. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
6. A. Falcone, S. Ricci, I. Brunetti Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest J Clin Oncol 25 2007 1670 1676
7. J.Y. Douillard, S. Siena, J. Cassidy Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study J Clin Oncol 28 2010 4697 4705
8. E. Van Cutsem, C.H. Khne, E. Hitre Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer N Engl J Med 360 2009 1408 1417
9. B.J. Giantonio, P.J. Catalano, N.J. Meropol Bevacizumab in combination with oxaliplatin, fluorouracil and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 J Clin Oncol 25 2007 1539 1544
10. D. Cunningham, Y. Humblet, S. Siena Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 2004 337 345
11. E. Van Cutsem, M. Peeters, S. Siena Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer J Clin Oncol 25 2007 1658 1664
12. B. Nordlinger, H. Sorbye, B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
13. M. Bouchahda, F. Levi, R. Adam Modern insights into hepatic arterial infusion for liver metastases from colorectal cancer Eur J Cancer 47 2011 2681 2690
14. J.A. Ridge, J.R. Bading, A.S. Gelbard Perfusion of colorectal hepatic metastases Relative distribution of flow from the hepatic artery and portal vein Cancer 59 1987 1547 1553
15. G. Bengtsson, G. Carlsson, L. Hafstrm Natural history of patients with untreated liver metastases from colorectal cancer Am J Surg 141 1981 586 589
16. L. Weiss, E. Grundmann, J. Torhorst Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies J Pathol 150 1986 195 203
17. D.J. Kerr, G. Los Pharmacokinetic principles of locoregional chemotherapy Cancer Surv 17 1993 105 122
18. S. Mocellin, P. Pilati, M. Lise Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 25 2007 5649 5654
19. J.N. Munck, M. Riggi, P. Rougier Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model Cancer Res 53 1993 1550 1554
20. R. Dzodic, G. Gomez-Abuin, P. Rougier Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model Anticancer Drugs 15 2004 647 650
21. S. Mocellin, S. Pasquali, D. Nitti Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer Cochrane Database Syst Rev 3 2009 CD007823
22. N.E. Kemeny, F.D. Melendez, M. Capanu Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma J Clin Oncol 27 2009 3465 3471
23. N. Kemeny, A. Eid, J. Stockman Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma J Surg Oncol 91 2005 97 101
24. N. Kemeny, K. Seiter, D. Niedzwiecki A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer Cancer 69 1992 327 334
25. G. Folprecht, A. Grothey, S. Alberts Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates Ann Oncol 16 2005 1311 1319
26. J.M. van Riel, C.J. van Groeningen, M.A. Kedde Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study Clin Cancer Res 8 2002 405 412
27. J.M. van Riel, C.J. van Groeningen, J. de Greve Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver Ann Oncol 15 2004 59 63
28. G. Fiorentini, S.R. Lucchi, P. Giovanis Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: results of a phase I clinical study Tumori 87 2001 388 390
29. G. Fiorentini, S. Rossi, P. Dentico Irinotecan hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase II clinical study Tumori 89 2003 382 384
30. Y. Chen, Z. Yan, J. Wang Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer Anticancer Res 30 2010 3045 3049
31. M. Bouchahda, R. Adam, S. Giacchetti Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer Cancer 115 2009 4990 4999
32. V. Boige, D. Malka, D. Elias Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure Ann Surg Oncol 15 2008 219 226
33. M. Ducreux, M. Ychou, A. Laplanche Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer J Clin Oncol 23 2005 4881 4887
34. D. Gor, I. Deshaies, T. de Baere Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases Ann Surg 251 2010 686 691
35. W. Kern, B. Beckert, N. Lang Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer Ann Oncol 12 2001 599 603
36. A. Mancuso, R. Giuliani, C. Accettura Hepatic arterial continuous infusion of oxaliplatin in patients with unresectable liver metastases from colorectal cancer Anticancer Res 23 2003 1917 1922
37. I. Guthoff, E. Lotspeich, C. Fester Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility Anticancer Res 23 2003 5203 5208
38. G. Fiorentini, S. Rossi, P. Dentico Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study Anticancer Res 24 2004 2093 2096
39. A. Del Freo, G. Fiorentini, F. Sanguinetti Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer In Vivo 20 2006 743 746
40. R.C. Martin, J. Joshi, K. Robbins Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 2011 192 198
41. P. Rougier, J.N. Munck, D. Elias Intra-arterial hepatic chemotherapy with pirarubicin Preclinical and clinical studies Am J Clin Oncol 13 suppl 1 1990 S1 S4
42. D. Fallik, M. Ychou, J. Jacob Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer Ann Oncol 14 2003 856 863
43. N.E. Kemeny, W.R. Jarnagin, M. Capanu Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer J Clin Oncol 29 2011 884 889
44. M.M. Kemeny, S. Adak, B. Gray Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapyan intergroup study J Clin Oncol 20 2002 1499 1505
45. N. Kemeny, Y. Huang, A.M. Cohen Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 1999 2039 2048
46. N.E. Kemeny, M. Gonen Hepatic arterial infusion after liver resection N Engl J Med 352 2005 734 735
47. N.J. Lygidakis, G. Sgourakis, L. Vlachos Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resectionresults of a prospective randomized study Hepatogastroenterology 48 2001 1685 1691
48. M. Lorenz, H.H. Mller, H. Schramm Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer: German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen) Ann Surg 228 1998 756 762
49. N.E. Kemeny, W.R. Jarnagin, M. Capanu Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer J Clin Oncol 29 2011 884 889
50. A. Kennedy, S. Nag, R. Salem Recommendations for radioembolization of hepatic malignancies using yttrium-90 microspheres brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
51. R. Salem, K. Thurston Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies Part 1: technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278
52. Kennedy A, Salem R. Comparison of two yttrium microspheres agents for hepatic artery brachytherapy. Proceedings of the 14th International Congress on Anti-Cancer Treatment, Paris, France, 2003:156.
53. M.A. Vente, M. Wondergem, I. van der Tweel Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis Eur Radiol 19 2009 951 959
54. P. Flamen, B. Vanderlinden, P. Delatte Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with yttrium-90 labeled resin microspheres Phys Med Biol 53 2008 6591 6603
55. M. Bienert, B. McCook, B. Carr 90Y microspheres treatment of unresectable liver metastases: change in the FDG uptake and tumor size on PET-CT Eur J Nucl Med Mol Imaging 32 2005 778 787
56. C. Marns, J. Andrews, I. Francis Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings Radiology 187 1993 125 128
57. R.A. Sharma, G.A. Van Hazel, B. Morgan Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106
58. G.A. van Hazel, N. Pavlakis, D. Goldstein Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy J Clin Oncol 27 2009 4089 4095
59. L. Lim, P. Gibbs, D. Yip A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-Fu based chemotherapy BMC Cancer 5 2005 132
60. A. Kennedy, D. Coldwell, C. Nutting Resin 90Y-microspheres brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 2006 412 425
61. R. Stubbs, I. O'Brien, M. Correia Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single centre experience with 1000 patients ANZ J Surg 76 2006 696 703
62. B. Gray, G. Van Hazel, M. Hope Randomized trial of SIR-spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 2001 1711 1720
63. G. Van Hazel, A. Blackwell, J. Anderson Randomized phase 2 trial of SIR-spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2004 78 85
64. A. Hendlisz, M. Van den Eynde, M. Peeters Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 2010 3687 3694
65. R. Timmerman, L. Papiez, R. McGarry Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
66. L.A. Dawson, T.S. Lawrence The role of radiotherapy in the treatment of liver metastases Cancer J 10 2004 139 144
67. A.E. van der Pool, A. Mndez Romero, W. Wunderink Stereotactic body radiation therapy for colorectal liver metastases Br J Surg 97 2010 377 382